DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • May 9th, 2018 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionThis Development and License Agreement (this “Agreement”) is made effective as of the date of the last signature below (the “Effective Date”) by and between Bayer HealthCare AG, a German corporation (“Bayer”), with its principal place of business at D-51369 Leverkusen, Germany, and ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, USA. Bayer and ImmunoGen are sometimes each hereinafter referred to individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • October 10th, 2012 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 10th, 2012 Company Industry JurisdictionThis Development and License Agreement (this “Agreement”) is made effective as of the date of the last signature below (the “Effective Date”) by and between Bayer HealthCare AG, a German corporation (“Bayer”), with its principal place of business at D-51369 Leverkusen, Germany, and ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, USA. Bayer and ImmunoGen are sometimes each hereinafter referred to individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • May 10th, 2012 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 10th, 2012 Company Industry JurisdictionThis Development and License Agreement (this “Agreement”) is made effective as of the date of the last signature below (the “Effective Date”) by and between Bayer HealthCare AG, a German corporation (“Bayer”), with its principal place of business at D-51369 Leverkusen, Germany, and ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451, USA. Bayer and ImmunoGen are sometimes each hereinafter referred to individually as a “Party” and collectively as the “Parties”.